Letters
Mersey has changed its policy
BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6985.1009 (Published 15 April 1995) Cite this as: BMJ 1995;310:1009
- Richard C Worth,
- J N McGalliard,
- A Harley
- Consultant physician Countess of Chester Hospital, Chester CH2 1BQ
- Consultant ophthalmologist Royal Liverpool University Hospital, Liverpool L7 8XP
- Consultant cardiologist Cardiothoracic Centre, Liverpool L14 3PE
EDITOR,—We agree with Helen Ward and John S Yudkin that diabetic retinopathy should not be a contraindication to the use of thrombolysis in myocardial infarction.1 In September 1991 one of us (RCW) expressed concern locally that the practical difficulty of excluding diabetic retinopathy could easily lead to diabetic patients being denied thrombolysis. The need for a rapid decision, often without the benefit …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.